Hideo Sasai

Dr. Hideo Sasai

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2020 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
HOHiroki Otsuka
Hiroki Otsuka
TKTakeshi Kimura
Takeshi Kimura
YAYasuhiko Ago
Yasuhiko Ago
MNMina Nakama
Mina Nakama
YAYuka Aoyama
Yuka Aoyama
TFToshiyuki Fukao
Toshiyuki Fukao


Verified
Journal Article
Open access
PDF file
NSNobuyuki Shimozawa
Nobuyuki Shimozawa
STShigeo Takashima
Shigeo Takashima
HKHiroki Kawai
Hiroki Kawai
KKKazuo Kubota
Kazuo Kubota
HSHideo Sasai
Hideo Sasai
HOHidenori Ohnishi
Hidenori Ohnishi
We established a diagnostic system for adrenoleukodystrophy (ALD) and peroxisomal disorders (PD) over 35 years ago in Japan, and have diagnosed 237 families with ALD and more than 100 cases of PD other than ALD using biochemical and molecular analyses. In particular, since the only treatment for the cerebral form of ALD is hematopoietic stem cell transplantation at an early stage of onset, we have developed a protocol for the rapid diagnosis of ALD that can provide the measurements of the levels of very-long-chain fatty acids in the serum and genetic analysis within a few days. In addition, to improve the prognosis of patients with ALD, we are working on the detection of pre-symptomatic patients by familial analysis from the proband, and the introduction of newborn screening. In this review, we introduce the diagnostic and newborn screening approaches for ALD and PD in Japan.

Verified
Journal Article
Open access
PDF file
GTGo Tajima
Go Tajima
RKReiko Kagawa
Reiko Kagawa
FSFumiaki Sakura
Fumiaki Sakura
AUAkari Utsunomiya
Akari Utsunomiya
KHKeiichi Hara
Keiichi Hara
SOSatoshi Okada
Satoshi Okada
Propionic acidemia (PA) is a disorder of organic acid metabolism which typically presents with acute encephalopathy-like symptoms associated with metabolic acidosis and hyperammonemia during the neonatal period. The estimated incidence of symptomatic PA in Japan is 1/400,000. The introduction of neonatal screening using tandem mass spectrometry has revealed a far higher disease frequency of approximately 1/45,000 live births due to a prevalent variant of c.1304T>C (p.Y435C) in PCCB, which codes β-subunit of propionyl-CoA carboxylase. Our questionnaire-based follow-up study reveals that most of these patients remain asymptomatic. However, reports on symptomatic patients exhibiting cardiac complications such as cardiomyopathy and QT prolongation have been increasing. Moreover, there were even cases in which these cardiac complications were the only symptoms related to PA. A currently ongoing study is investigating the risk of cardiac complications in patients with neonatal screening-detected PA caused by this common variant.

1 January 2015 in The Tohoku Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
HSHideo Sasai
Hideo Sasai
NSNobuyuki Shimozawa
Nobuyuki Shimozawa
TATakahiko Asano
Takahiko Asano
NKNorio Kawamoto
Norio Kawamoto
TYTakahiro Yamamoto
Takahiro Yamamoto
TFToshiyuki Fukao
Toshiyuki Fukao
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

25 March 2022 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
YOYoshimitsu Osawa
Yoshimitsu Osawa
HKHironori Kobayashi
Hironori Kobayashi
GTGo Tajima
Go Tajima
KHKeiichi Hara
Keiichi Hara
KYKenji Yamada
Kenji Yamada
TTTakeshi Taketani
Takeshi Taketani